H LUNDBECK A S [Rocket]

Date Filed	Type	Description
10/24/2019	SC 13D/A	H LUNDBECK A S reports a 100% stake in ALDER BIOPHARMACEUTICALS, INC.
10/22/2019	SC TO-T/A	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/17/2019	SC TO-T/A	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/10/2019	SC TO-T/A	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/04/2019	SC TO-T/A	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/01/2019	SC TO-T/A	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
09/27/2019	SC TO-T/A	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
09/26/2019	SC 13D	H LUNDBECK A S reports a 13.3% stake in ALDER BIOPHARMACEUTICALS, INC.
09/23/2019	SC TO-T	Form SC TO-T - Tender offer statement by Third Party:
09/18/2019	SC TO-C	Form SC TO-C - Written communication relating to an issuer or third party:
09/16/2019	SC TO-C	Form SC TO-C - Written communication relating to an issuer or third party:
06/23/2014	SC TO-T/A	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
06/19/2014	SC TO-T/A	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
06/11/2014	SC TO-T/A	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
06/06/2014	SC TO-T/A	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
05/23/2014	SC TO-T	Form SC TO-T - Tender offer statement by Third Party:
05/08/2014	SC TO-C	Form SC TO-C - Written communication relating to an issuer or third party:
03/06/2003	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/27/2002	SC 13D	H LUNDBECK A S reports a 36.9% stake in SYNAPTIC PHARMACEUTICAL CORPORATION